Episodes
-
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: William F.C. Rigby, MD
Polymyalgia rheumatica (PMR) is an inflammatory rheumatic condition that can be difficult to diagnose and treat. For instance, PMR is a diagnosis of exclusion, and it can mimic a wide variety of other conditions. And once a patient is accurately diagnosed, the standard-of-care treatment with glucocorticoids may result in toxicity for some patients. Learn more about these and other diagnostic and treatment challenges as well as other treatment options with Dr. Charles Turck and Dr. William Rigby, Professor of Medicine and of Microbiology and Immunology at the Geisel School of Medicine at Dartmouth.
© 2024 Sanofi and Regeneron Pharmaceuticals, Inc.
All rights reserved.
MAT-US-2403256 v1.0 - P
Expiration Date 04/16/2025 -
Guest: Jason Busse, PhD
In light of the opioid epidemic, the use of cannabis for therapeutic purposes is becoming of interest. But since there are other alternatives that are often more effective and have better safety profiles, it’s important to understand the evidence and guideline recommendations around these two treatment options. Here to share key considerations for using opioids and cannabis to treat patients living with chronic pain is Dr. Jason Busse, who presented a session on this exact topic at the 2024 Congress of Clinical Rheumatology.
-
Episodes manquant?
-
Guest: Jason Busse, PhD
Different clinical practice guidelines often have discrepancies from one another, making it a challenge for clinicians to determine which ones are more trustworthy. Here to break down the things clinicians should look for when sorting between guidelines that give discrepant recommendations is Dr. Jason Busse, who presented a session on this exact topic at the 2024 Congress of Clinical Rheumatology.
-
Host: Michael Lewiecki, MD, FACP, FACE
Although step therapy is the approach that many health plans and organizations are fond of, individualizing treatment decisions for patients with osteoporosis is essential, especially those who are at risk of fractures. To learn how you can create personalized treatment plans for patients with osteoporosis, tune in to hear Dr. Michael Lewiecki give us a recap of the session he presented at the 2024 Congress of Clinical Rheumatology.
-
Host: Michael Lewiecki, MD, FACP, FACE
Here to talk about current concepts in the management of osteoporosis like insurance coverage, therapy sequencing, and comparative effectiveness is Dr. Michael Lewiecki, who presented a session on this exact topic at the 2024 Congress of Clinical Rheumatology.
-
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: John Stone, MD, MPH
Glucocorticoids are often successfully used as the mainstay of treatment for many inflammatory conditions, but adverse events associated with glucocorticoids use are common. Fortunately, there are steps we can take to reduce the risk of glucocorticoid toxicity, like monitoring patients, educating them on the possible side effects, and considering alternative treatments where available. Tune in to learn more about the side effects, risk factors, and prevention strategies with Dr. Charles Turck and Dr. John Stone.
© 2024 Sanofi and Regeneron Pharmaceuticals, Inc. All rights reserved.
MAT-US-2310647 v1.0 - P
Expiration Date 04/16/2025 -
Host: Monica Schwartzman, MD, MS
Guest: Joerg Ermann, MD
Axial spondyloarthritis is a chronic inflammatory rheumatic disease that affects the axial skeleton causing severe pain, stiffness, and fatigue. Fortunately, advances in its management have vastly improved symptoms and quality of life for our patients. So what exactly are the developments that have been made in the treatment of this disease? Tune in as Dr. Monica Schwartzman is joined by Dr. Joerg Ermann to discuss the recent therapeutic advances in axial spondyloarthritis.
